序号 |
标题 |
次数 |
作者 |
发布时间 |
80731 |
DOTA-Maleimide 1006711-90-5 DOTA-马来酰亚胺 |
106 |
zcy |
2024-11-28 |
80732 |
DOTA-PEG(4)-BN(7-14) , DOTA-PESIN , 8-氨基酸肽铃蟾肽(7-14)偶联大环螯合剂DOTA |
108 |
kx |
2024-11-28 |
80733 |
β-环糊精七价MUC1糖肽缀合物 |
151 |
h |
2024-11-28 |
80734 |
DOTA-CH2-Alkynyl(HCl salt) |
79 |
zyl |
2024-11-28 |
80735 |
DOTA-p-NH2-Bn 181065-46-3 DOTA-P-苯-氨基 |
96 |
zcy |
2024-11-28 |
80736 |
**银纳米粒-环糊精金属有机骨架复合物 |
95 |
h |
2024-11-28 |
80737 |
DOTA-Amide|CAS:157599-02-5|四氨基修饰大环配体 |
109 |
zyl |
2024-11-28 |
80738 |
甘草次酸/环糊精-金属有机骨架复合物 GTA-CD-MOFs |
116 |
h |
2024-11-28 |
80739 |
DOTA-DGlu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 , DOTA-MG11 |
64 |
kx |
2024-11-28 |
80740 |
环糊精金属有机骨架载维生素A棕榈酸酯 VAP与γ-CD-MOF |
200 |
h |
2024-11-28 |
80741 |
DOTA-(COOt-Bu)3-Mal |
62 |
zyl |
2024-11-28 |
80742 |
γ-CD-MOFs负载姜黄素 Cur-CD-MOFs |
154 |
h |
2024-11-28 |
80743 |
DOTA肽结合血管粘附蛋白-1 , DOTAVAP-P1 |
120 |
kx |
2024-11-28 |
80744 |
DOTATATE(又称为DOTA-octreotide)DOTA-3-酪氨酰基-奥曲肽 |
243 |
zcy |
2024-11-28 |
80745 |
Bz-DOTA-ABD-(Z(HER2:342) , Bz-DOTA偶联ABD-(Z(HER2:342))(2) |
79 |
kx |
2024-11-28 |
80746 |
M-AMF-DOTA(Nd)衍生物 |
111 |
kx |
2024-11-28 |
80747 |
CAS:1402795-92-9 DOTA-(COOt-Bu)3-azide |
146 |
zyl |
2024-11-28 |
80748 |
大环1,4,7,10-四氮杂环十二烷-N,N’,N”,N”-四乙酸(C-DOTA)的钆-树枝状聚合物缀合物 |
89 |
kx |
2024-11-28 |
80749 |
DO-(CH2COOH)2 二乙酸脱氧核酸 |
108 |
zyl |
2024-11-28 |
80750 |
3,3′-偶氮双(6-氨基-1,2,4,5-四嗪)(DAAT) |
106 |
WYQ |
2024-11-28 |
80751 |
3,6-双(1-氢-四唑-5-氨基)-1,2,4,5-四嗪(BTATz) |
88 |
WYQ |
2024-11-28 |
80752 |
CAS:593287-40-2 大环化合物 |
83 |
zyl |
2024-11-28 |
80753 |
3,6-二叠氮基-1,2,4,5-四嗪(DiAT) |
85 |
WYQ |
2024-11-28 |
80754 |
CAS:1027785-95-0 Ga-DOTA-NOC |
118 |
zyl |
2024-11-28 |
80755 |
DOTAGA-rhCCK-9 |
86 |
wyh |
2024-11-28 |
80756 |
DOTA-Dglu-(Glu)5-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2的结构组成 |
100 |
wyh |
2024-11-28 |
80757 |
polylysine-(Gd-DOTA)的介绍 |
105 |
zyl |
2024-11-28 |
80758 |
(R)-DOTAGA-(COOt-Bu)4 817562-90-6 (R)-DOTAGA-四叔丁酯 |
94 |
zcy |
2024-11-28 |
80759 |
Azido-mono-amide-DOTA(B-288) |
129 |
zyl |
2024-11-28 |
80760 |
DOTA-PEGn-Cys-VS;单分散PEG偶联螯合剂DOTA |
105 |
wyh |
2024-11-28 |
80761 |
3-羟基-5-取代芳基吡唑[3,4-e]并-1,2,3,4-四嗪衍生物 |
100 |
WYQ |
2024-11-28 |
80762 |
氨基羧酸盐大环NOTA (N(3)O(3)) |
154 |
kx |
2024-11-28 |
80763 |
3,6-二对氯苯基-1,4-二氢-S-四嗪-1,4-二对甲基苯砜基 |
85 |
WYQ |
2024-11-28 |
80764 |
CAS:437608-50-9 Lutathera |
148 |
zyl |
2024-11-28 |
80765 |
3,6-二丙基-N,N'-二甲苯基-1,2,4,5-四嗪-1,4-二甲酰胺 |
92 |
WYQ |
2024-11-28 |
80766 |
DOTA-PEGn-Cys-VS;单分散PEG偶联螯合剂DOTA |
75 |
wyh |
2024-11-28 |
80767 |
3,6-二胺基-1,2,4,5-四嗪(DAT) |
113 |
WYQ |
2024-11-28 |
80768 |
CAS:2057438-24-9 Dotatate tfa |
77 |
zyl |
2024-11-28 |
80769 |
3,6-二(对氯苄基)-s-四嗪 |
79 |
WYQ |
2024-11-28 |
80770 |
DOTA-cBR96 , DOTA偶联BR96单克隆抗体 |
100 |
kx |
2024-11-28 |
80771 |
p-NH2-Bn-DOTA-hu14.18K322A |
109 |
wyh |
2024-11-28 |
80772 |
3,6-二(对氯苯基)-s-四嗪 |
85 |
WYQ |
2024-11-28 |
80773 |
DOTA-tri(acid)-amido-PEG3-Bromoacetamide 定制 |
95 |
zcy |
2024-11-28 |
80774 |
CAS:306776-79-4 DOTAGA-tetra (t-Bu ester) |
106 |
zyl |
2024-11-28 |
80775 |
N,N'-二取代基-3,6-二取代苯基-1,4-二氢-S-四嗪-1,4-二甲酰胺类化合物 |
104 |
WYQ |
2024-11-28 |